Correlation Between Cumberland Pharmaceuticals and Bank of America

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cumberland Pharmaceuticals and Bank of America at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cumberland Pharmaceuticals and Bank of America into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cumberland Pharmaceuticals and Bank of America, you can compare the effects of market volatilities on Cumberland Pharmaceuticals and Bank of America and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cumberland Pharmaceuticals with a short position of Bank of America. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cumberland Pharmaceuticals and Bank of America.

Diversification Opportunities for Cumberland Pharmaceuticals and Bank of America

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cumberland and Bank is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Cumberland Pharmaceuticals and Bank of America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bank of America and Cumberland Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cumberland Pharmaceuticals are associated (or correlated) with Bank of America. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bank of America has no effect on the direction of Cumberland Pharmaceuticals i.e., Cumberland Pharmaceuticals and Bank of America go up and down completely randomly.

Pair Corralation between Cumberland Pharmaceuticals and Bank of America

Given the investment horizon of 90 days Cumberland Pharmaceuticals is expected to generate 3.2 times less return on investment than Bank of America. In addition to that, Cumberland Pharmaceuticals is 6.19 times more volatile than Bank of America. It trades about 0.0 of its total potential returns per unit of risk. Bank of America is currently generating about 0.07 per unit of volatility. If you would invest  2,192  in Bank of America on September 1, 2024 and sell it today you would earn a total of  106.00  from holding Bank of America or generate 4.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Cumberland Pharmaceuticals  vs.  Bank of America

 Performance 
       Timeline  
Cumberland Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cumberland Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, Cumberland Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Bank of America 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bank of America are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable essential indicators, Bank of America is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Cumberland Pharmaceuticals and Bank of America Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cumberland Pharmaceuticals and Bank of America

The main advantage of trading using opposite Cumberland Pharmaceuticals and Bank of America positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cumberland Pharmaceuticals position performs unexpectedly, Bank of America can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bank of America will offset losses from the drop in Bank of America's long position.
The idea behind Cumberland Pharmaceuticals and Bank of America pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets